Epigenetic Biomarkers Are Applicable for Risk Stratification in Myelodysplastic Syndromes

被引：1
|
作者：
Mies, Anna [1 ]
Bozic, Tanja [2 ]
Kramer, Michael [1 ]
Franzen, Julia [2 ]
Ehninger, Gerhard [1 ]
Bornhauser, Martin [1 ,3 ]
Platzbecker, Uwe [1 ,3 ]
Wagner, Wolfgang [2 ]
机构：
[1] Univ Hosp Carl Gustav Carus Dresden, Dept Internal Med 1, Dresden, Germany
[2] RWTH Aachen Med Sch, Helmholtz Inst Biomed Engn, Stem Cell Biol & Cellular Engn, Aachen, Germany
[3] German Canc Consortium, Heidelberg, Germany
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3194.3194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3194
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management
    Tefferi, Ayalew
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (09) : 831 - 831
  • [22] Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (07) : 692 - 701
  • [23] Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
    Mosquera Orgueira, Adrian
    Perez Encinas, Manuel Mateo
    Diaz Varela, Nicolas A.
    Mora, Elvira
    Diaz-Beya, Marina
    Montoro, Maria Julia
    Pomares, Helena
    Ramos, Fernando
    Tormo, Mar
    Jerez, Andres
    Nomdedeu, Josep F.
    De Miguel Sanchez, Carlos
    Leonor, Arenillas
    Carcel, Paula
    Cedena Romero, Maria Teresa
    Xicoy, Blanca
    Rivero, Eugenia
    del Orbe Barreto, Rafael Andres
    Diez-Campelo, Maria
    Benlloch, Luis E.
    Crucitti, Davide
    Valcarcel, David
    HEMASPHERE, 2023, 7 (10): : E961
  • [24] Mutations in epigenetic regulators in myelodysplastic syndromes
    Nikoloski, Gorica
    van der Reijden, Bert A.
    Jansen, Joop H.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (01) : 8 - 16
  • [25] Mutations in epigenetic regulators in myelodysplastic syndromes
    Gorica Nikoloski
    Bert A. van der Reijden
    Joop H. Jansen
    International Journal of Hematology, 2012, 95 : 8 - 16
  • [26] Editorial: Epigenetic biomarkers for cancer risk stratification and patient management
    Tanic, Miljana
    Ecker, Simone
    Lyskjaer, Iben
    FRONTIERS IN GENETICS, 2024, 15
  • [27] There's Risk, and Then There's RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes
    Zeidan, Amer M.
    Komrokji, Rami S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (04) : 351 - 360
  • [28] There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes
    Amer M. Zeidan
    Rami S. Komrokji
    Current Hematologic Malignancy Reports, 2013, 8 : 351 - 360
  • [29] MYELODYSPLASTIC SYNDROMES: AN INTEGRATED MOLECULAR/CYTOGENETIC WORKUP FOR A CORRECT PATIENTS' RISK STRATIFICATION
    Galimberti, S.
    Ciabatti, E.
    Grassi, S.
    Ferreri, M. I.
    Valetto, A.
    Guerrini, F.
    Guazzelli, A.
    Azzara, A.
    Metelli, M. R.
    Simi, P.
    Petrini, M.
    HAEMATOLOGICA, 2014, 99 : 345 - 345
  • [30] Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age
    Xie, Zhuoer
    Chen, Evan C.
    Stahl, Maximilian
    Zeidan, Amer M.
    BLOOD REVIEWS, 2023, 59
12345